SCHEMBL19183151

SCHEMBL19183151

CNC(=O)CS(=O)(=O)N1CCC(CNC(=O)O)CC1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.40
L3MBTL1 Q9Y468 2/20 0.40
MMP3 P08254 2/20 0.39
EPHX2 P34913 2/20 0.39
CYP2D6 P10635 1/20 0.39
KDM4E B2RXH2 2/20 0.38
POLB P06746 1/20 0.38
PKM P14618 1/20 0.35
HDAC3 O15379 1/20 0.35
HDAC4 P56524 1/20 0.35
HDAC1 Q13547 1/20 0.35
HDAC7 Q8WUI4 1/20 0.35
HDAC2 Q92769 1/20 0.35
HDAC10 Q969S8 1/20 0.35
HDAC11 Q96DB2 1/20 0.35
HDAC8 Q9BY41 1/20 0.35
HDAC6 Q9UBN7 1/20 0.35
HDAC9 Q9UKV0 1/20 0.35
HDAC5 Q9UQL6 1/20 0.35
ALOX15 P16050 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17711673 0.85 KDM4E (0.50) ALDH1A1L3MBTL1EPHX2CYP2D6KDM4E
SCHEMBL19201204 0.82 DRD2 (0.43) KDM4EPKM
SCHEMBL19201203 0.81 NCF1 (0.39) ALDH1A1L3MBTL1MMP3EPHX2KDM4E
Hydrochloric Acid SCHEMBL21570515 0.79 NCF1 (0.38) ALDH1A1L3MBTL1MMP3EPHX2KDM4E
SCHEMBL19183136 0.79 ALDH1A1 (0.43) ALDH1A1L3MBTL1EPHX2CYP2D6KDM4E
SCHEMBL17711743 0.79 TP53 (0.49) ALDH1A1L3MBTL1EPHX2CYP2D6KDM4E
SCHEMBL2697931 0.73 TSHR (0.46) ALDH1A1L3MBTL1EPHX2CYP2D6KDM4E
SCHEMBL18547134 0.72 ALDH1A1 (0.42) ALDH1A1L3MBTL1EPHX2CYP2D6KDM4E
SCHEMBL16494745 0.71 CYP2D6 (0.50) EPHX2CYP2D6HDAC4HDAC1HDAC2
SCHEMBL23573524 0.68 EPHX2 (0.56) EPHX2CYP2D6KDM4EPKMHDAC3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3939974-A1 MODULATORS OF ROR-GAMMA Vitae Pharmaceuticals, LLC (US) 2022-01-19 EP disclosed
EP-3408268-B1 BENZIMIDAZOLE DERIVATIVES AS MODULATORS OF ROR-GAMMA VITAE PHARMACEUTICALS LLC (US) 2021-08-04 EP disclosed
US-20210094940-A1 MODULATORS OF ROR-GAMMA VITAE PHARMACEUTICALS, LLC 2021-04-01 US disclosed
US-10829481-B2 Benzimidazole derivatives as modulators of ROR-gamma VITAE PHARMACEUTICALS, LLC (US) 2020-11-10 US disclosed
US-20190352286-A1 BENZIMIDAZOLE DERIVATIVES AS MODULATORS OF ROR-GAMMA VITAE PHARMACEUTICALS, LLC 2019-11-21 US disclosed
EP-3408268-A1 BENZIMIDAZOLE DERIVATIVES AS MODULATORS OF ROR-GAMMA Vitae Pharmaceuticals, Inc. (US) 2018-12-05 EP disclosed
WO-2017132432-A1 BENZIMIDAZOLE DERIVATIVES AS MODULATORS OF ROR-GAMMA VITAE PHARMACEUTICALS, INC. (US) 2017-08-03 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190352286-A1 BENZIMIDAZOLE DERIVATIVES AS MODULATORS OF ROR-GAMMA RORB, RORC, RORA ALDH1A1 397/4885L3MBTL1 4069/4885MMP3 4580/4885
US-10829481-B2 Benzimidazole derivatives as modulators of ROR-gamma RORB, RORC, RORA ALDH1A1 236/4885L3MBTL1 4539/4885MMP3 4478/4885
US-20210094940-A1 MODULATORS OF ROR-GAMMA RORC, RORB, RORA ALDH1A1 546/4885L3MBTL1 4673/4885MMP3 4394/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.